Effective treatment with tocilizumab in a rheumatoid arthritis patient complicated with human T-cell leukemia virus type 1-associated myelopathy

2Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

A 61-year-old woman with human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy (HAM)/ tropical spastic paraparesis (TSP) and interstitial pneumonia (IP) was admitted to our hospital. She complained of sicca symptoms, polyarthralgia, and swollen joints. She was diagnosed with rheumatoid arthritis (RA) and Sjögren’s syndrome. Methotrexate and anti-tumor necrosis factor therapy were not utilized because of the inclusion of severe respiratory disorders among the complications and the neurological symptoms of HAM/TSP. Tocilizumab monotherapy improved the RA disease activity without exacerbating HAM/TSP. The present case suggests that tocilizumab might be a suitable treatment option in patients with RA and HAM/ TSP.

Cite

CITATION STYLE

APA

Iwao, C., Umekita, K., Miyauchi, S., Kimura, M., Rikitake, Y., Iwao, K., … Okayama, A. (2020). Effective treatment with tocilizumab in a rheumatoid arthritis patient complicated with human T-cell leukemia virus type 1-associated myelopathy. Internal Medicine, 59(15), 1891–1897. https://doi.org/10.2169/internalmedicine.4455-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free